(NP (NP Characterization/NN) (PP of/IN (NP (NP Grb2-binding/JJ proteins/NNS) (PP in/IN (NP (NP human/JJ platelets/NNS) (VP activated/VBN (NP */-NONE-) (PP by/IN (NP-LGS Fc/NN gamma/NN RIIA/NN cross-linking/NN))))))) ./.)
(S (NP-SBJ-68 (ADJP Glutathione-S-transferase/NN -LRB-/-LRB- GST/NN -RRB-/-RRB- -Grb2/NN) fusion/NN proteins/NNS) (VP have/VBP (VP been/VBN (VP used/VBN (NP *-68/-NONE-) (S (NP-SBJ */-NONE-) (VP to/TO (VP identify/VB (NP (NP the/DT potential/JJ role/NN) (PP of/IN (NP Grb2-binding/JJ proteins/NNS)) (PP in/IN (NP (NP platelet/NN activation/NN) (PP by/IN (NP (NP the/DT platelet/NN low-affinity/NN IgG/NN receptor/NN) ,/, (NP Fc/NN gamma/NN RIIA/NN)))))))))))) ./.)
(S (NP-SBJ (NP Two/CD tyrosine/NN phosphoproteins/NNS) (PP of/IN (NP (QP 38/CD and/CC 63/CD) kD/NN))) (VP bind/VBP (PP to/TO (NP (NP the/DT SH2/NN domain/NN) (PP of/IN (NP Grb2/NN)))) (PP-TMP following/VBG (NP (NP Fc/NN gamma/NN RIIA/NN stimulation/NN) (PP of/IN (NP platelets/NNS))))) ./.)
(S (NP-SBJ-69 Both/DT) (VP-COOD (VP are/VBP (ADJP-PRD located/JJ (PP in/IN (NP the/DT particulate/JJ fraction/NN))) (PP-TMP following/VBG (NP platelet/NN activation/NN))) and/CC (VP are/VBP (ADVP also/RB) (ADJP-PRD able/JJ (S (NP-SBJ *-69/-NONE-) (VP to/TO (VP bind/VB (PP to/TO (NP (NP a/DT GST-construct/NN) (VP containing/VBG (NP (NP the/DT (NP-COOD (NP SH2/NN) and/CC (NP SH3/NN)) domains/NNS) (PP of/IN (NP phospholipase/NN C/NN gamma/NN 1/CD)))))))))))) ./.)
(S (NP-SBJ p38/NN) (VP-COOD (VP (ADVP also/RB) forms/VBZ (NP a/DT complex/NN) (PP with/IN (NP the/DT tyrosine/NN kinase/NN csk/NN)) (PP in/IN (NP stimulated/VBN cells/NNS))) and/CC (VP is/VBZ (NP-PRD (NP a/DT substrate/NN) (PP for/IN (NP the/DT kinase/NN))))) ./.)
(S (NP-SBJ (NP The/DT SH3/NN domains/NNS) (PP of/IN (NP Grb2/NN))) (VP form/VBP (NP a/DT stable/JJ complex/NN) (PP with/IN (NP-COOD (NP SOS1/NN) and/CC (NP (NP two/CD proteins/NNS) (PP of/IN (NP-COOD (NP 75/CD kD/NN) and/CC (NP 120/CD kD/NN))) ,/, (SBAR (WHNP-71 which/WDT) (S (NP-SBJ *T*-71/-NONE-) (VP undergo/VBP (NP tyrosine/NN phosphorylation/NN) (PP in/IN (NP (ADJP (NP Fc/NN gamma/NN RIIA/NN) stimulated/JJ) cells/NNS))))))))) ./.)
(S (NP-SBJ-74 The/DT 75-kD/JJ protein/NN) (VP is/VBZ (VP-COOD (VP recognized/VBN (NP *-74/-NONE-) (PP by/IN (NP-LGS (NP antibodies/NNS) (PP to/TO (NP (NP SLP-76/NN) ,/, (SBAR (WHNP-75 which/WDT) (S (NP-SBJ-76 *T*-75/-NONE-) (VP has/VBZ (ADVP-TMP recently/RB) (VP been/VBN (VP isolated/VBN (NP *-76/-NONE-) (PP from/IN (NP T/NN cells/NNS)))))))))))) and/CC (VP sequenced/VBN (NP *-74/-NONE-)))) ./.)
(S (NP-SBJ-77 (NP Tyrosine/NN phosphorylation/NN) (PP of/IN (NP-COOD (NP p38/NN) and/CC (NP p63/NN)))) (VP is/VBZ (ADVP also/RB) (VP observed/VBN (NP *-77/-NONE-) (PP in/IN (NP (NP platelets/NNS) (VP stimulated/VBN (NP */-NONE-) (PP-COOD (PP by/IN (NP-LGS the/DT (ADJP tyrosine/NN kinase-linked/JJ) receptor/NN agonist/NN collagen/NN)) and/CC (PP by/IN (NP-LGS the/DT (ADJP G/NN protein-coupled/JJ) receptor/NN agonist/NN thrombin/NN)))))) ,/, (SBAR although/IN (S (NP-SBJ-78 (NP phosphorylation/NN) (PP of/IN (NP SLP-76/NN))) (VP is/VBZ (ADVP only/RB) (VP observed/VBN (NP *-78/-NONE-) (PP in/IN (NP collagen-stimulated/JJ platelets/NNS)))))))) ./.)
(S (NP-SBJ-COOD-79 (NP p38/NN) and/CC (NP p63/NN)) (VP may/MD (VP provide/VB (NP (NP a/DT docking/NN site/NN) (PP for/IN (NP Grb2/NN))) ,/, (S (NP-SBJ *-79/-NONE-) (ADVP thereby/RB) (VP linking/VBG (NP Grb2/NN SH3-binding/JJ proteins/NNS (NP-COOD (NP SOS1/NN) ,/, (NP SLP-76/NN) ,/, and/CC (NP p120/NN))) (PP to/TO (NP downstream/JJ signalling/NN events/NNS)))))) ./.)
